> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# APOE ε4 carriers show steeper age-related changes in plasma Alzheimer's disease biomarkers
- URL: https://www.coios.me/apoe-4-carriers-show-steeper-age-related-changes-in-plasma/
- Published: 2026-11-18T13:08:28.000Z
- Updated: 2026-11-18T13:58:31.000Z
- Description: In 5,913 cognitively normal Dutch adults, three plasma Alzheimer's biomarkers diverged by APOE ε4 status between ages 53 and 63.
- Author: Daniel Ryan
- Tags: Health today, Dementia, What linked data reveals, Netherlands, #peer-reviewed, #refines, #item, #source-2026-11, #score-68

Plasma p-tau217, amyloid-β-42/40, NfL and GFAP were measured in 5,913 cognitively normal Netherlands Twin Register adults aged 30 to 80\. The study tested how APOE ε4, a polygenic risk score excluding APOE, age and sex related to these biomarkers. Carriers and non-carriers diverged at 53.2 years for amyloid-β-42/40, 58.8 for p-tau217 and 62.8 for GFAP, but not for NfL. The polygenic risk score did not alter how any biomarker changed with age. In 202 older twins with amyloid PET scans, p-tau217 rose faster where amyloid was present. Carrying ε4 was linked to an earlier rise. The main cohort was cross-sectional and family-based, and cognition was not formally tested.

*Why it is interesting: Plasma p-tau217, amyloid-β-42/40 and GFAP differed by APOE ε4 status 15 to 20 years before estimated mean clinical onset. These differences appeared in adults reporting no memory complaints.*

Source

[Nature Communications, 16 November 2026](https://doi.org/10.1038/s41467-026-78723-2?ref=coios.me)

DOI

10.1038/s41467-026-78723-2

Full text

[Open copy](https://pmc.ncbi.nlm.nih.gov/articles/PMC13774448/?ref=coios.me) (open-access copy, PubMed Central)

Type

Peer-reviewed article

Design

Population-based cross-sectional cohort analysis, Netherlands Twin Register, n=5913 aged 30-80, with longitudinal replication in EMIF-AD

Verdict

Refines prior evidence

Driver

[Dementia](https://www.coios.me/d-dementia/)

Driver

[What linked data reveals](https://www.coios.me/d-linked-data/)